May 7, 2009
Stock to watch – Sequenom (SQNM)
The expected launch of its SEQureDx™ Down syndrome test by Sequenom (SQNM) is delayed, due to the discovery by company officials of employee mishandling of R&D test data and results. Accordingly the company is no longer relying on the previously announced R&D test data and results.
Related posts:
- The best stock to invest in during recession Altira has
